Thinking of joining a study?

Register your interest

NCT05875129 | Recruiting | Cancer


Device Feasibility and Acceptability to Improve Insomnia in Cancer
Sponsor:

Medstar Health Research Institute

Brief Summary:

Sleep disruption is common among young adult cancer survivors for a variety of reasons. Cognitive behavioral therapy for insomnia (CBT-I) has been shown to improve chronic sleep disorders. This project will test the feasibility and acceptability of a new voice-activated virtual assistant (VAVA) device to deliver CBT-I to improve sleep among young adult cancer survivors with chronic sleep disorders.

Condition or disease

Cancer

Insomnia Chronic

Intervention/treatment

VAVA prototype

Phase

Not Applicable

Detailed Description:

Sleep is a complex biobehavioral event, impacted by interactions between the individual's physiology as well as their environment. Young adult cancer survivors (YACS; those between 18- 29 years of age) are a growing group of survivors, numbering close to 400,000 in the US. They are among those at highest risk for chronically insufficient sleep due to developmentally normative biological and social factors, compounded by their extensive medical treatment history. Cognitive-behavioral therapy for insomnia (CBT-I) is recommended by the American College of Physicians as gold standard treatment for insomnia disorder and has been successfully adapted for YACS. Fundamental CBT-I strategies can be implemented to change the problematic sleep behaviors that result in insufficient sleep among young adults. However, it is essential that these evidence-based strategies be deployed to be responsive to the specific barriers to sleep for YACS. This feasibility/acceptability study will test the use of an integrated VAVA that offers the opportunity to implement intervention strategies in a way that repeatedly gives YACS the chance to make the right decision with respect to their sleep health in real time.

Study Type : Interventional
Estimated Enrollment : 15 participants
Masking: None (Open Label)
Primary Purpose: Device Feasibility
Official Title: Intervention for Chronic Insufficient Sleep in Young Adult Cancer Survivors
Actual Study Start Date : July 20, 2023
Estimated Primary Completion Date : December 31, 2023
Estimated Study Completion Date : December 31, 2023
Arm Intervention/treatment

Experimental: Intervention arm

Participants (N=15) will will be provided with the VAVA prototype along with installation instructions to embed the VAVA within their homes. We provide them with a smart speaker running our intervention, a smart lamp, and a new router. They will be asked to trial the VAVA for a period of 2 weeks, a duration consistent with the primary stage of CBT-I treatment.

Device: VAVA prototype

Ages Eligible for Study: 18 Years to 39 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria
  • age between 18 and 29 years old
  • history of cancer (any type, any stage)
  • chronic sleep loss as evidence by self-report of receiving less sleep than recommended for their age by the National Sleep Foundation for >/= 3 months
  • must have an internet router in their primary home that they have access to (can add a second router to for the system to work)
Exclusion Criteria
  • acute medical/psychiatric disorder requiring treatment
  • developmental or congenital disorder
  • life expectancy <12 months.

Device Feasibility and Acceptability to Improve Insomnia in Cancer

Location Details


Please Choose a site



Device Feasibility and Acceptability to Improve Insomnia in Cancer

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Recruiting

United States, District of Columbia

MedStar Washington Hospital Center

Washington, District of Columbia, United States, 20010

Loading...